Psoriasis: Differential Diagnosis, Paradoxical Responses, and New Treatment Mechanisms

54TH ANNUAL EUROPEAN SOCIETY FOR DERMATOLOGICAL RESEARCH MEETING (ESDR) | ANTWERP, BELGIUM

September 10, 2025

| 13:00 – 17:00 CEST

Location: Flanders Meeting & Convention Center Antwerp (“A Room with a Zoo”), Okapi 2-3, Ground Floor, Carnot Wing

Add this symposium to your calendar

Agenda

Welcome and Introduction
Lluís Puig, MD, PhD, Spain

SECTION 1: PATHOMECHANISMS

Immune Shifts in Psoriasis
Michel Gilliet, MD, Switzerland

Where Does Psoriasis Fit into the Differential Diagnosis of Contact Dermatitis?
Julien Lambert, PhD, Belgium

Paradoxical Psoriasis and Therapeutic Approaches
Paola Di Meglio, PhD, United Kingdom

Drug-Induced Psoriasis
Deepak Balak, MD, PhD, MSc, Netherlands

Panel Discussion
Section 1 Faculty
Moderator: Jo Lambert, MD, PhD, Belgium

BREAK

SECTION 2: TREATMENT MECHANISMS

Mechanisms of Topical Drug Delivery: Opportunities for Psoriasis?
Robert Rissmann, PhD, Netherlands

Oral Drug Development: History and Future Prospects
Curdin Conrad, MD, Switzerland

Panel Discussion
Section 2 Faculty
Moderator: Lluís Puig, MD, PhD, Spain

Abstract Presentations

Closing and Adjourn
Jo Lambert, MD, PhD, Belgium

Program Chairs

Program Faculty

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

What's New

Skin-Derived Myeloid Precursors and Joint-Resident Fibroblasts Spread Psoriatic Disease from Skin to Joints

IPC Councilor Helen Young provides commentary on a study identifying skin-derived myeloid precursors and CD200+ fibroblasts as key drivers of psoriatic disease spread from the skin to joints, highlighting the CD200–CD200R1 axis as a promising therapeutic target.

Tuesday, June 23, 2026

Fellow Perspectives | Psoriasis Care in Ethiopia: Challenges and Opportunities for Progress

IPC Fellow Dr. Yemsrach Abawaji shares her firsthand perspective on the barriers to psoriasis diagnosis and treatment in Ethiopia and opportunities to improve care.

Monday, June 22, 2026

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Psoriasis: Differential Diagnosis, Paradoxical Responses, and New Treatment Mechanisms

54TH ANNUAL EUROPEAN SOCIETY FOR DERMATOLOGICAL RESEARCH MEETING (ESDR) | ANTWERP, BELGIUM

Agenda

Program Chairs

Hospital de la Santa Creu i Sant Pau

Barcelona, Spain

IPC Board Member

Ghent University Hospital

Ghent, Belgium

IPC Councilor

Program Faculty

Leiden University Medical Center

Leiden, Netherlands

IPC Jr. Councilor

University Hospital of Lausanne

Lausanne, Switzerland

IPC Board Member

King’s College London

London, United Kingdom

IPC Councilor

University of Lausanne

Lausanne, Switzerland

IPC Councilor

University Hospital of Antwerp

Antwerp, Belgium

Centre for Human Drug Research

Leiden, Netherlands

This symposium is supported in part by

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Thursday, June 11, 2026